Hepatitis C Stocks
3357 views
Rate Now: 1 2 3 4

average rating: 3.00 / 0 ratings
Created by Guest
DESCRIPTION:

Date updated:11-16-2006

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.

symbol name last price % change open
  • +
  • HGSI
    Human Genome Scie
  • $27.38
  • +0.59%
  • $26.89

Human Genome Sciences is developing a drug, Albuferon, that patients in a midstage trial of it are reporting better quality of life although it is at an early stage. They agreed to jointly market it with Swiss pharmaceutical giant Novartis but the risk is the late stage clinical trials could show it not to be as effective as investors hoped.

People owning HGSI also tend to own: ALXNAVNRBCRXCORDCGNDSCOEXEL

TheStreet.com Rating: D+ What is this?

  • +
  • IDIX
    Idenix Pharmaceut
  • $1.84
  • 0.00%
  • $N/A

Idenix Pharmaceuticals has partnered with Novartis on its drug, NM283. The drug has modest potency but is undergoing a trial in combination interferon and ribvirin that may show better results. Roche has a competing drug that may be more potent but it has to be given in higher doses. The trial for Idenix will hopefully clear things up.

People owning IDIX also tend to own: CAMPCEGEELNKFCELJBLUTALKTIE

TheStreet.com Rating: D- What is this?

  • +
  • ITMN
    Intermune
  • $10.79
  • -0.83%
  • $10.965

Intermune of Brisbane, CA has partnered with Swisds pharmaceutical titan Roche on several of its drugs. There have been no trials yet (one is planned for year end) so this is definitely speculative.

People owning ITMN also tend to own: AMMDARRYBVFCAHCBSTCELGCI

TheStreet.com Rating: D What is this?

  • +
  • SGP
    Sgp
  • $0.00
  • N/A
  • $N/A

Schering-Plough is an established playerin the treatment of Hepatitis C with a few different drugs which brought in 750M in sales last year. They have a few new drugs that are in development right now.

People owning SGP also tend to own: AMGNAPABACCCOPCVXDOW

TheStreet.com Rating: No Rating What is this?

  • +
  • VRTX
    Vertex Pharmaceut
  • $38.54
  • -0.98%
  • $38.88

Vertex is the leader in the pack for drugs treating the virus. The small to mid-stage clinical trial results were spectacular. In June, the company signed a deal with Johnson & Johnson to codevelop the drug in which J&J obtained most foreign rights. Vertex shares have quadrupled over the past 2 years on optimism about its drug.

People owning VRTX also tend to own: EXPEIACIMCDXECAGPALXNATU

TheStreet.com Rating: D- What is this?

  • +
  • VPHM
    Viropharma Incorp
  • $7.70
  • +3.36%
  • $7.50

In August, ViroPharma of Exton, PA said data from an early stage trial of its drug reduced the virus 99% after 14 days of treatment in combination with interferon.

People owning VPHM also tend to own: ASPVHANSESLRSLABAAPLAMGNBBY

TheStreet.com Rating: C- What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...

11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...

11.19.09 | 11:13 AM
Squeezing the Shorts: Earnings G...

By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...

11.18.09 | 12:36 PM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Simple headline speak "1,00...
11.23.09 | 00:02 AM From author graspthemarket
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
more forums
Q. Am I diversified? My major hold...
11.22.09 | 21:36 PM Asked by fwtrader

A. a sector pair but not an industry pair
AAPL/AMT

today 's lists
Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

Cramer's Lightning Round

These are the stocks from Jim Cramer's Nov. 1 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more

Analyst Downgrades

Analyst Downgrades or Estimate Reductions for Nov. 20, 2009. Read more here. more